Cigna says AI tools to save customers $200 million in medical expenses over three years

July 23, 2026 7:17 AM EDT

FILE PHOTO: A screen displays the logo fro Cigna Corp. on the floor at the New York Stock Exchange (NYSE) in New York, U.S., July 16, 2019. REUTERS/Brendan McDermid/File Photo

By Amina Niasse

NEW YORK, ‌July 23 (Reuters) - ​Health ​insurer Cigna said on Thursday that the artificial intelligence tools it is employing to identify patients with ‌chronic or complex conditions will save customers $200 million in ⁠medical costs over the next three years.

Bryan Holgerson, a president at Cigna ‌Healthcare, said the technology should ‌reduce occurrences of more expensive health events, as costs for hospitalization and emergency services continue to increase. Cigna, using ​AI tools, plans to connect more members in its health insurance business to clinicians the company employs, such as ⁠nurses.

Cigna said the programming will allow its 1,250 clinicians to better manage a patient's ​healthcare needs and offer customized support earlier.

The changes will boost clinical access by 20% for people with ​conditions like cancer and heart ‌or kidney disease, Cigna said in a press release. Cigna said it expects its new technology ⁠to help identify breast, colorectal and lung cancer earlier.

A Cigna spokesperson said company data estimates that customers using these clinical programs save $2,000 a ⁠year in medical costs.

The Cigna Group owns health insurer Cigna Healthcare, clinical ​business Evernorth Health Services and a pharmacy benefit manager, Express Scripts.

Rival UnitedHealth last week said tools the company has introduced this year have ‌reduced the administrative burden for clinicians it employs through its Optum health services unit and increased ‌the amount of time providers can spend treating patients.

CVS Health last ⁠week announced it plans ‌to launch an AI assistant ​to call providers directly and book appointments on behalf of members.

(Reporting by Amina Niasse; Editing by Will ‌Dunham)



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Reuters